Page last updated: 2024-08-26

ici 164384 and Metastase

ici 164384 has been researched along with Metastase in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berns, EM; Foekens, JA; Jansen, MP; Look, MP; Reijm, EA; Ruigrok-Ritstier, K; Sieuwerts, AM; Sleijfer, S; van Gelder, ME; van Staveren, IL	1

Other Studies

1 other study(ies) available for ici 164384 and Metastase

Article	Year
Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer. Breast cancer research and treatment, 2011, Volume: 125, Issue:2 Topics: Antineoplastic Agents, Hormonal; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Fluorescent Antibody Technique; Gene Silencing; Humans; Neoplasm Metastasis; Polycomb Repressive Complex 2; Polymerase Chain Reaction; Polyunsaturated Alkamides; Prognosis; RNA, Messenger; RNA, Small Interfering; Tamoxifen; Transcription Factors; Treatment Outcome	2011

Article

Year

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer.

Breast cancer research and treatment, 2011, Volume: 125, Issue:2

Topics: Antineoplastic Agents, Hormonal; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Fluorescent Antibody Technique; Gene Silencing; Humans; Neoplasm Metastasis; Polycomb Repressive Complex 2; Polymerase Chain Reaction; Polyunsaturated Alkamides; Prognosis; RNA, Messenger; RNA, Small Interfering; Tamoxifen; Transcription Factors; Treatment Outcome

2011